Video content above is prompted by the following questions: How do you educate and counsel patients who want to consider or are currently using a JAK inhibitor? How do you discuss treatment targets and manage patient expectations? What suggestions do you have for patients and healthcare professionals to optimize treatment of AD with JAK inhibitors?